Effectiveness of Bupropion for Treating Nicotine Dependence in Young People

Completed · Phase 2 · Has a placebo group

Conditions studied: Tobacco Use Cessation, Tobacco Use Disorder

In brief

Little is known about the best ways to help young people stop smoking. Bupropion (a medication marketed as Wellbutrin or Zyban) has proved helpful in treating adult smokers. The purpose of this study is to determine if bupropion is also effective in treating smokers between the ages of 12 and 25 years old. This study also compares the effectiveness of bupropion used as a supplement to behavioral treatment versus behavioral treatment used alone. In addition, the study evaluates whether hormonal response to stress measured prior to the start of treatment predicts whether individuals respond well to treatment with medication.

Key facts

Study ID
NCT00129272
Run by
National Institute on Drug Abuse (NIDA)
People needed
172
Starts
2004-05-01
Expected to finish
2011-01-01
Last updated by the study team
2017-05-22

Who can join

Age: 12 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.